Managing Dental Medical Integration

1. What is the patient's complete medical history, including all active diagnoses?
2. What is the patient's current medication list, including OTC supplements and herbal products?
3. Does the patient have drug allergies, with reaction type specified (true allergy vs. intolerance)?
4. What is the patient's ASA Physical Status classification (I through VI)?
5. Has the patient been hospitalized or had surgery in the past 12 months?
6. Does the patient have any implanted devices (pacemaker, joint prosthesis, heart valve)?
7. Is the patient currently receiving chemotherapy, radiation therapy, or immunosuppressive therapy?
8. What is the planned dental procedure and its expected stress level (mild, moderate, significant)?

Documents to Request

• Completed medical history questionnaire (ADA Health History Form or equivalent)
• Current medication list from pharmacy or patient portal
• Most recent lab values (HbA1c, INR/PT, CBC, BMP) when medically relevant
• Physician consultation letter (when medical clearance is needed)
• Radiation therapy records (field, dose, dates) for head and neck cancer patients
• Bisphosphonate/denosumab treatment history (drug, route, duration, indication)
• Cardiology clearance for patients with recent cardiac events
• Allergy documentation with reaction details

Step 1: ASA Classification and Risk Stratification

ASA Physical Status Classification for Dental

Risk Assessment Domains

1. Bleeding risk: Anticoagulants, antiplatelets, coagulopathies, liver disease
2. Infection risk: Immunosuppression, uncontrolled diabetes, neutropenia, endocarditis risk
3. Cardiovascular risk: Hypertension, arrhythmias, recent MI, heart failure
4. Airway/respiratory risk: Asthma, COPD, obstructive sleep apnea, morbid obesity
5. Drug interaction risk: MAOIs with vasoconstrictors, calcium channel blockers with gingival hyperplasia
6. Metabolic risk: Adrenal insufficiency, thyroid disease, diabetes, renal failure

Step 2: Systemic Disease-Specific Dental Protocols

Diabetes Mellitus

Anticoagulant and Antiplatelet Therapy

Bisphosphonate / Denosumab and MRONJ Risk

Infective Endocarditis Prophylaxis (2021 AHA/ACC Updated Guideline)

Prophylaxis recommended ONLY for patients with:

• Prosthetic cardiac valves or prosthetic material used for valve repair
• Previous infective endocarditis
• Certain congenital heart defects (unrepaired cyanotic, repaired with residual defect, repaired with prosthetic material < 6 months)
• Cardiac transplant with valvulopathy

Standard regimen: Amoxicillin 2 g PO, 30–60 minutes before procedure. Penicillin-allergic alternatives: Clindamycin 600 mg PO, Azithromycin 500 mg PO, or Cephalexin 2 g PO.

Step 3: Physician Consultation Process

When to Consult

• ASA III or IV patients undergoing invasive procedures
• Anticoagulated patients requiring surgical extractions or implant placement
• Patients on IV bisphosphonates or denosumab before any extraction
• Patients with recent cardiac event (MI, stroke, CABG within 6 months)
• Patients on active chemotherapy or immunosuppressive therapy
• Uncontrolled hypertension (systolic > 180 or diastolic > 110 in the dental chair)
• Any situation where the dentist is uncertain about safe treatment modification

Consultation Letter Template Elements

1. Patient identifying information
2. Specific dental procedure planned (with expected duration and stress level)
3. Specific medical question being asked (e.g., "Is it safe to proceed with extraction given current warfarin therapy with INR 2.8?")
4. Current medications relevant to the dental procedure
5. Request for specific lab values or clearance
6. Preferred communication method and timeline

What NOT to Ask

• "Is the patient cleared for dental treatment?" — this is vague and unactionable
• Questions that fall within dental scope of practice (e.g., anesthetic selection)

Step 4: Treatment Modifications and Emergency Preparedness

Stress Reduction Protocol

1. Short morning appointments when cortisol levels are highest
2. Adequate pain control — profound local anesthesia before any stimulation
3. Limit epinephrine to 0.04 mg total (2 cartridges of 1:100,000) for cardiovascularly compromised patients
4. Consider nitrous oxide anxiolysis for anxious medically complex patients (contraindicated in COPD, severe CHF)
5. Monitor vital signs before, during, and after procedure for ASA III+ patients

Medical Emergency Preparedness

Every dental office managing medically complex patients must maintain:

• Automated external defibrillator (AED)
• Emergency drug kit (epinephrine 1:1,000 for anaphylaxis, nitroglycerin, albuterol, aspirin, diphenhydramine, oral glucose)
• Supplemental oxygen with appropriate delivery devices
• Current BLS certification for all clinical staff
• Written emergency protocols posted and rehearsed quarterly

Step 5: Head and Neck Radiation and Chemotherapy Patients

Pre-Radiation Dental Protocol

1. Complete comprehensive dental evaluation BEFORE radiation therapy begins
2. Extract teeth with poor prognosis in the radiation field (hopeless periodontal, non-restorable caries, impacted)
3. Allow minimum 14–21 days healing before radiation starts
4. Fabricate custom fluoride trays for daily 1.1% NaF gel application (lifelong)
5. Restore all carious teeth; optimize periodontal health

Post-Radiation Dental Considerations

Chemotherapy Dental Protocol

• Complete dental clearance BEFORE chemotherapy if possible
• During active chemotherapy: defer elective dental treatment
• Monitor for oral mucositis, candidiasis, and herpes simplex reactivation
• Before invasive dental procedures during chemo: verify ANC > 1,000/mm³ and platelets > 50,000/mm³
• Consult oncologist for timing of dental procedures relative to chemotherapy cycles

Checkpoint B: Post-Treatment Alignment (Mandatory)

1. Were all identified medical conditions addressed in the treatment plan with documented modifications?
2. Was physician consultation obtained when indicated, with written response on file?
3. Were current lab values verified before procedures affected by medication or disease status?
4. Was the appropriate antibiotic prophylaxis regimen administered (or documented as not indicated)?
5. Were post-operative instructions tailored to the patient's medical conditions (e.g., bleeding precautions for anticoagulated patients)?

Quality Audit

Guidelines

• Never discontinue a patient's anticoagulant or antiplatelet medication without explicit direction from the prescribing physician — the thrombotic risk almost always outweighs the dental bleeding risk
• Update the medical history at every visit — a patient's medical status can change between appointments
• "Medical clearance" is not a binary concept; frame consultation requests as specific clinical questions with specific dental procedures
• Document the decision-making process when treating medically complex patients, including risks discussed and informed consent for modifications
• Maintain current knowledge of AHA endocarditis prophylaxis guidelines — these have narrowed significantly since 2007 and are frequently over-applied
• For head and neck radiation patients, perform dental evaluation and necessary extractions BEFORE radiation begins when possible; post-radiation extraction carries significant osteoradionecrosis risk
• When in doubt about proceeding, delay elective treatment and consult — the risk of a dental complication from a deferred cleaning is almost always lower than the risk of a medical emergency from an uninformed procedure
• Coordinate with the patient's medical team using secure, HIPAA-compliant communication channels